SRCircumventing imatinib resistance
Authors:
Open Access
- 31 August 2004
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 6 (2) , 108-110
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Overriding Imatinib Resistance with a Novel ABL Kinase InhibitorScience, 2004
- Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinibBlood, 2003
- Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapyLeukemia, 2002
- Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemiaCancer Cell, 2002
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000